Novel Peptides in Resistant Human Hypertension
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Nesiritide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Dec 2016 Status changed from suspended to discontinued.
- 08 Nov 2013 Planned end date changed from 1 Jan 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov record.